Form 4: Sera Prognostics Chief Scientific Officer Boniface Sells Shares Under 10b5-1 Plan

John J. Boniface, Chief Scientific Officer of Sera Prognostics, sold 22,163 shares of Class A Common Stock at $9.1 per share on March 25, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Summary

• On March 25, 2024, John J. Boniface, the Chief Scientific Officer of Sera Prognostics, sold 22,163 shares of Class A Common Stock.
• The sale was executed at a price of $9.1 per share.
• This transaction was conducted under a Rule 10b5-1 trading plan adopted on December 15, 2023.
• Following the transaction, Boniface directly owns 164,962 shares of Sera Prognostics.
• The Form 4 filing was signed by Benjamin G. Jackson, Attorney-in-fact, on March 26, 2024.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it's a routine disclosure of an insider sale under a pre-arranged trading plan. It doesn't necessarily indicate a positive or negative outlook for the company.

Industry Context

This filing is a routine disclosure of insider trading activity. It's common for executives to use 10b5-1 plans to sell shares over time to avoid accusations of trading on inside information.

Stakeholder Impact

• The sale of shares by a company executive could be perceived negatively by some shareholders, although the existence of a 10b5-1 plan mitigates this concern.

Key Dates